By Professor Dedee Frances Murrell

Journal articles

Cowan TL; Makhija M; Murrell DF, 2022, 'Pemphigoid gestationis and preeclampsia in a donor-egg IVF pregnancy', International Journal of Women S Dermatology, 8, http://dx.doi.org/10.1097/JW9.0000000000000026

Guignant M; Tedbirt B; Murrell DF; Amagai M; Aoki V; Bauer J; Ciancinni G; Culton D; Daneshpazhooh M; De D; Fairley J; Hall R; Kim SC; Korman NJ; Kowalewski C; Mimouni D; Patsatsi A; Hebert V; Saleh MAM; Schmidt E; Sprecher E; Uzun S; Venning V; Werth VP; Zillikens D; Joly P, 2022, 'How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International Survey', Jid Innovations, 2, http://dx.doi.org/10.1016/j.xjidi.2022.100129

COWAN T; WALLMAN L; MURRELL D, 2022, 'Severe bullous pemphigoid after Vaxzevria COVID-19 vaccination', Mucosa, 5, pp. 27 - 29, http://dx.doi.org/10.33204/mucosa.993581

Wilson A; Murrell DF, 2022, 'Clinical features of chronic bullous dermatosis of childhood', Clinical and Experimental Dermatology, 47, pp. 873 - 881, http://dx.doi.org/10.1111/ced.15059

Rathod D; Kroumpouzos G; Lallas A; Rao B; Murrell DF; Apalla Z; Grabbe S; Loquai C; Goldust M, 2022, 'Critical Review of the Sentinel Lymph Node Surgery in Malignant Melanoma', Journal of Drugs in Dermatology, 21, pp. 510 - 516, http://dx.doi.org/10.36849/JDD.6198

Wilson B; Sun M; Chennareddy S; Murrell D; Murase J, 2022, 'An Analysis of Skin of Color Publications in the Journal of Drugs in Dermatology from 2018 to 2020', Journal of drugs in dermatology : JDD, 21, pp. 441 - 442, http://dx.doi.org/10.36849/JDD.6286

Greenblatt DT; Pillay E; Snelson K; Saad R; Torres Pradilla M; Widhiati S; Diem A; Knight C; Thompson K; Azzopardi N; Werkentoft M; Moore Z; Patton D; Mayre-Chilton KM; Murrell DF; Mellerio JE, 2022, 'Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus-based guideline*', British Journal of Dermatology, 186, pp. 620 - 632, http://dx.doi.org/10.1111/bjd.20809

Behkar A; Garmaroudi G; Nasimi M; Yousefi S; Khosravi H; Kianfar N; Murrell DF; Daneshpazhooh M, 2022, 'Assessing quality of life in patients with autoimmune bullous diseases using the persian version of treatment of autoimmune bullous disease quality of life questionnaire finds similar effects in women as men', International Journal of Women S Dermatology, 8, http://dx.doi.org/10.1097/JW9.0000000000000004

Sun M; Wilson BN; Zhou RZ; Murrell DF; Murase JE, 2022, 'Evaluation of skin of color content in Skin Research and Technology', Skin Research and Technology, 28, pp. 355 - 356, http://dx.doi.org/10.1111/srt.13105

Liang Y; Zeng FAP; Sheriff T; Wilson A; Bilgic A; Feng G; Stone JH; Murrell DF, 2022, 'Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort study', JAAD International, 6, pp. 68 - 76, http://dx.doi.org/10.1016/j.jdin.2021.09.003

Bishnoi A; Manjunath S; Kishore K; De D; Handa S; Murrell DF; Mahajan R, 2022, 'Hindi translation and validation of quality of life score in Indian patients with epidermolysis bullosa; and its correlation with the clinical severity assessment scores: A cross-sectional study', Indian Journal of Dermatology Venereology and Leprology, 88, pp. 177 - 183, http://dx.doi.org/10.25259/IJDVL_31_20

Wilson BN; Sun M; Shah R; Murrell DF; Murase JE, 2022, 'Purposeful inclusion of skin of colour in published literature for improved dermatology education: a call to action', Clinical and Experimental Dermatology, 47, pp. 409 - 410, http://dx.doi.org/10.1111/ced.14821

Fölster-Holst R; Torrelo A; Das K; Murrell DF; Patil A; Rahmat Pour Rokni G; Grabbe S; Staubach P; Sohn A; Goldust M, 2022, 'Biological medication in atopic dermatitis', Expert Opinion on Biological Therapy, 22, pp. 643 - 649, http://dx.doi.org/10.1080/14712598.2022.2026920

Wu D; Daniel BS; Lai AJX; Wong N; Lim DKA; Murrell DF; Lim BXH; Mehta JS; Lim CHL, 2022, 'Proposed management algorithm for dupilumab-associated ocular side effects: a collaborative effort between dermatologists and ophthalmologists', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.18397

Wilson B; Sun M; Revankar R; Murrell D; Murase J, 2022, 'Three-Year Assessment of Diversity and Skin of Color Content in Dermatitis', Dermatitis, 33, pp. E6 - E7, http://dx.doi.org/10.1097/DER.0000000000000813

Khosrotehrani K; Murrell D; Veysey E; Tong P; Bennett H; Mar V; Soyer HP, 2022, 'Training and Retaining Physician‒Scientists in Dermatology: Australia', Jid Innovations, 2, http://dx.doi.org/10.1016/j.xjidi.2021.100074

Hall R; Culton DA; Liu Z; Ujiie H; Schmidt E; Murrell D; Stoykov I; Verheesen P; Borradori L; Joly P, 2022, '070 Treating Bullous Pemphigoid by Inhibiting FcRn: A Phase 2/3 Trial with Efgartigimod', Journal of Investigative Dermatology, 142, pp. S192 - S192, http://dx.doi.org/10.1016/j.jid.2022.09.079

Murrell DF; Bruckner AL; Davis C; Maher L; Cunningham T; Summeray M, 2022, '34650 Correlation between wound burden and procedural pain in patients with EB ≥4 years of age: An exploratory analysis from the EASE study', Journal of the American Academy of Dermatology, 87, pp. AB152 - AB152, http://dx.doi.org/10.1016/j.jaad.2022.06.641

Lee LW; Kern JS; Murrell D; Löwe S; Maher L; Cunnigham T, 2022, 'LB970 Effect of Oleogel-S10 (birch triterpenes) on dressing change frequency and wound infection in epidermolysis bullosa: Analysis from the EASE study', Journal of Investigative Dermatology, 142, pp. B22 - B22, http://dx.doi.org/10.1016/j.jid.2022.05.992

Chogani F; Parvizi MM; Murrell DF; Handjani F, 2021, 'Assessing the quality of life in the families of patients with epidermolysis bullosa: The mothers as main caregivers', International Journal of Women S Dermatology, 7, pp. 721 - 726, http://dx.doi.org/10.1016/j.ijwd.2021.08.007

Revankar R; Murrell DF; Murase JE, 2021, 'Shedding light on the impact of hidradenitis suppurativa on women and their families: A focus of the International Journal of Women's Dermatology', International Journal of Women S Dermatology, 7, pp. 661 - 663, http://dx.doi.org/10.1016/j.ijwd.2021.08.005

Zeng FAP; Murrell DF, 2021, 'State-of-the-art review of human autoimmune blistering diseases (AIBD)', Veterinary Dermatology, 32, pp. 524 - e145, http://dx.doi.org/10.1111/vde.13008

Kossard S; Sheriff T; Murrell D, 2021, 'T-Cell-Driven Fibroinflammation Inducing Follicular Dedifferentiation in Alopecia Areata and IgG4-Modified Disease', American Journal of Dermatopathology, 43, pp. 955 - 961, http://dx.doi.org/10.1097/DAD.0000000000001992

Ho G; Murrell DF, 2021, 'Angiosarcoma presenting as unexplainable unilateral leg pain and purpuric toes', Medical Journal of Australia, 215, pp. 456, http://dx.doi.org/10.5694/mja2.51310

Kang M; Chen JSC; Radjenovic M; Yang A; Feng GHY; Murrell DF, 2021, 'An analysis of the prevalence of osteoporosis and osteopenia in patients with epidermolysis bullosa: A cross-sectional study', Experimental Dermatology, 30, pp. 1675 - 1685, http://dx.doi.org/10.1111/exd.14252

Sun MD; Wilson BN; Weitzman S; Ren J; Murrell DF; Murase JE, 2021, 'Assessment of published literature regarding skin of color in Pediatric Dermatology', Pediatric Dermatology, 38, pp. 1604 - 1605, http://dx.doi.org/10.1111/pde.14823

Sun MD; Wilson BN; Zhou RZ; Murrell DF; Murase JE, 2021, 'Evaluating diversity in Clinics in Dermatology: Diversity in clinics in dermatology: M. Sun et al.', Clinics in Dermatology, 39, pp. 1064 - 1066, http://dx.doi.org/10.1016/j.clindermatol.2021.07.010

Eng VA; Solis DC; Gorell ES; Choi S; Nazaroff J; Li S; de Souza MP; Murrell DF; Marinkovich MP; Tang JY, 2021, 'Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey', Journal of the American Academy of Dermatology, 85, pp. 1161 - 1167, http://dx.doi.org/10.1016/j.jaad.2020.03.028

Schmidt E; Rashid H; Marzano AV; Lamberts A; Di Zenzo G; Diercks GFH; Alberti-Violetti S; Barry RJ; Borradori L; Caproni M; Carey B; Carrozzo M; Cianchini G; Corrà A; Dikkers FG; Feliciani C; Geerling G; Genovese G; Hertl M; Joly P; Meijer JM; Mercadante V; Murrell DF; Ormond M; Pas HH; Patsatsi A; Rauz S; van Rhijn BD; Roth M; Setterfield J; Zillikens D; C.Prost ; Zambruno G; Horváth B; Caux F, 2021, 'European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part II', Journal of the European Academy of Dermatology and Venereology, 35, pp. 1926 - 1948, http://dx.doi.org/10.1111/jdv.17395

Murrell DF; Patsatsi A; Stavropoulos P; Baum S; Zeeli T; Kern JS; Roussaki-Schulze AV; Sinclair R; Bassukas ID; Thomas D; Neale A; Arora P; Caux F; Werth VP; Gourlay SG; Joly P, 2021, 'Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study*', British Journal of Dermatology, 185, pp. 745 - 755, http://dx.doi.org/10.1111/bjd.20431

Wilson BN; Sun M; Ashbaugh AG; Ohri S; Yeh C; Murrell DF; Murase JE, 2021, 'Assessment of skin of color and diversity and inclusion content of dermatologic published literature: An analysis and call to action', International Journal of Women S Dermatology, 7, pp. 391 - 397, http://dx.doi.org/10.1016/j.ijwd.2021.04.001

Murase JE; Murrell DF, 2021, 'Embracing diversity in dermatology: Creation of a culture of inclusion in dermatologic publishing', International Journal of Women S Dermatology, 7, pp. 371 - 377, http://dx.doi.org/10.1016/j.ijwd.2021.08.001

Rashid H; Lamberts A; Borradori L; Alberti-Violetti S; Barry RJ; Caproni M; Carey B; Carrozzo M; Caux F; Cianchini G; Corrà A; Diercks GFH; Dikkers FG; Di Zenzo G; Feliciani C; Geerling G; Genovese G; Hertl M; Joly P; Marzano AV; Meijer JM; Mercadante V; Murrell DF; Ormond M; Pas HH; Patsatsi A; Prost C; Rauz S; van Rhijn BD; Roth M; Schmidt E; Setterfield J; Zambruno G; Zillikens D; Horváth B, 2021, 'European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part I', Journal of the European Academy of Dermatology and Venereology, 35, pp. 1750 - 1764, http://dx.doi.org/10.1111/jdv.17397

Clarke RA; Fang Z; Murrell D; Sherriff T; Eapen V, 2021, 'Gdf6 knockdown in a family with multiple synostosis syndrome and speech impairment', Genes, 12, http://dx.doi.org/10.3390/genes12091354

Fulchand S; Harris N; Li S; Barriga M; Gorell E; De Souza M; Murrell D; Marinkovich MP; Krishna Yenamandra V; Tang JY, 2021, 'Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross-sectional survey', Pediatric Dermatology, 38, pp. 1198 - 1201, http://dx.doi.org/10.1111/pde.14802

Su JC; Murashkin N; Wollenberg A; Svensson Å; Chernyshov P; Lio P; Murrell D; Nosbaum A; Faure S; Mery S; Stalder JF, 2021, 'Pharmacist recommendations regarding topical steroid use may contradict the standard of care in atopic dermatitis: An international, cross-sectional study', Jaad International, 4, pp. 13 - 14, http://dx.doi.org/10.1016/j.jdin.2021.04.005

Lin G; Murase JE; Murrell DF; Godoy LDC; Grant-Kels JM, 2021, 'The impact of gender in mentor–mentee success: Results from the Women's Dermatologic Society Mentorship Survey', International Journal of Women S Dermatology, 7, pp. 398 - 402, http://dx.doi.org/10.1016/j.ijwd.2021.04.010

Patsatsi A; Murrell DF, 2021, 'Bruton Tyrosine Kinase Inhibition and Its Role as an Emerging Treatment in Pemphigus', Frontiers in Medicine, 8, http://dx.doi.org/10.3389/fmed.2021.708071

Ho G; Blake SC; Sheriff T; Daniel BS; Murrell DF, 2021, 'Impact of COVID-19 on inpatient dermatology consults in an Australian tertiary hospital', Australasian Journal of Dermatology, 62, pp. 427 - 428, http://dx.doi.org/10.1111/ajd.13649

Ho G; Sheriff T; Doria-Ruiz M; Loh Y; Murrell DF, 2021, 'Are biosimilars for pemphigus safe?', Clinical and Experimental Dermatology, 46, pp. 942 - 943, http://dx.doi.org/10.1111/ced.14610

Murrell DF; Joly P; Werth VP, 2021, 'Individual patients’ risk factors impact guidelines for prophylactic agents used in pemphigus patients treated with rituximab', Journal of the American Academy of Dermatology, 85, pp. e47 - e48, http://dx.doi.org/10.1016/j.jaad.2021.03.018

Silverberg JI; Pinter A; Alavi A; Lynde C; Bouaziz JD; Wollenberg A; Murrell DF; Alpizar S; Laquer V; Chaouche K; Ahmad F; Armstrong JM; Piketty C, 2021, 'Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study', Journal of the European Academy of Dermatology and Venereology, 35, pp. 1562 - 1568, http://dx.doi.org/10.1111/jdv.17218

Montagnon CM; Tolkachjov SN; Murrell DF; Camilleri MJ; Lehman JS, 2021, 'Subepithelial autoimmune blistering dermatoses: Clinical features and diagnosis', Journal of the American Academy of Dermatology, 85, pp. 1 - 14, http://dx.doi.org/10.1016/j.jaad.2020.11.076

Montagnon CM; Lehman JS; Murrell DF; Camilleri MJ; Tolkachjov SN, 2021, 'Subepithelial autoimmune bullous dermatoses disease activity assessment and therapy', Journal of the American Academy of Dermatology, 85, pp. 18 - 27, http://dx.doi.org/10.1016/j.jaad.2020.05.161

Kasperkiewicz M; Schmidt E; Amagai M; Fairley JA; Joly P; Murrell DF; Payne AS; Yale ML; Zillikens D; Woodley DT, 2021, 'Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic', Journal of the European Academy of Dermatology and Venereology, 35, pp. e412 - e414, http://dx.doi.org/10.1111/jdv.17207

Murrell DF; Paul CF, 2021, 'What instruments should we add to our toolbox for measuring the severity and control of eczema?', British Journal of Dermatology, 185, pp. 13 - 14, http://dx.doi.org/10.1111/bjd.20398

Montagnon CM; Tolkachjov SN; Murrell DF; Camilleri MJ; Lehman JS, 2021, 'Intraepithelial autoimmune blistering dermatoses: Clinical features and diagnosis', Journal of the American Academy of Dermatology, 84, pp. 1507 - 1519, http://dx.doi.org/10.1016/j.jaad.2020.11.075

Montagnon CM; Lehman JS; Murrell DF; Camilleri MJ; Tolkachjov SN, 2021, 'Intraepithelial autoimmune bullous dermatoses disease activity assessment and therapy', Journal of the American Academy of Dermatology, 84, pp. 1523 - 1537, http://dx.doi.org/10.1016/j.jaad.2021.02.073

Murrell DF; Murase JE, 2021, 'The International Reach of the International Journal of Women's Dermatology and the Women's Dermatologic Society', International Journal of Women S Dermatology, 7, pp. 235 - 236, http://dx.doi.org/10.1016/j.ijwd.2021.05.004

Ramirez-Quizon M; Murrell DF, 2021, 'Managing epidermolysis bullosa during the coronavirus pandemic: Experience and ideals', Clinics in Dermatology, 39, pp. 369 - 373, http://dx.doi.org/10.1016/j.clindermatol.2021.01.014

Back to profile page